当前位置:首页 - 行情中心 - 益丰药房(603939) - 财务分析

益丰药房

(603939)

  

流通市值:285.47亿  总市值:285.53亿
流通股本:12.12亿   总股本:12.12亿

益丰药房(603939)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润11.98亿元,每股收益0.92元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1089970.61万元,未分配利润507634.11万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产2721150.23万元,负债1631179.62万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入17,218,897,862.7611,762,401,111.515,970,923,210.3522,588,227,402.22
营业总成本15,712,009,022.9210,676,892,508.965,394,533,467.5920,616,597,464.58
营业利润1,585,544,439.531,133,967,327.92593,522,472.652,054,785,114.19
利润总额1,579,992,160.751,131,496,444.03593,238,296.12,037,593,919.93
净利润1,198,418,466.02860,070,534.32445,951,883.351,580,930,945.44
其他综合收益-89,370,675-119,801,550-44,204,85038,418,418.54
综合收益总额1,109,047,791.02740,268,984.32401,747,033.351,619,349,363.98
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计14,674,572,132.8913,934,437,376.8513,948,585,480.4612,128,910,739.25
非流动资产合计12,536,930,162.8912,502,382,958.812,213,238,135.7712,007,628,455.39
资产总计27,211,502,295.7826,436,820,335.6526,161,823,616.2324,136,539,194.64
流动负债合计12,287,188,811.9411,406,905,552.1511,088,641,783.2611,269,471,260.25
非流动负债合计4,024,607,391.154,122,985,000.294,005,166,700.192,419,980,272.55
负债合计16,311,796,203.0915,529,890,552.4415,093,808,483.4513,689,451,532.8
归属于母公司股东权益合计10,253,079,010.0910,209,293,299.4310,393,858,921.249,804,432,476.56
股东权益合计10,899,706,092.6910,906,929,783.2111,068,015,132.7810,447,087,661.84
负债和股东权益合计27,211,502,295.7826,436,820,335.6526,161,823,616.2324,136,539,194.64
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计18,851,751,650.7512,774,703,986.926,196,262,045.2824,133,356,755.95
经营活动现金流出小计15,509,977,272.5610,953,005,669.65,546,154,840.0219,509,615,960.35
经营活动产生的现金流量净额3,341,774,378.181,821,698,317.33650,107,205.264,623,740,795.6
投资活动现金流入小计12,419,340,011.156,821,481,968.331,911,134,134.183,715,795,204.37
投资活动现金流出小计16,089,737,685.388,675,990,053.922,073,105,175.46,696,116,279.58
投资活动产生的现金流量净额-3,670,397,674.23-1,854,508,085.59-161,971,041.22-2,980,321,075.21
筹资活动现金流入小计1,810,363,0001,789,323,0001,785,372,00017,040,791
筹资活动现金流出小计1,901,026,355.341,216,954,556.01429,050,632.422,110,080,020.23
筹资活动产生的现金流量净额-90,663,355.34572,368,443.991,356,321,367.58-2,093,039,229.23
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-419,286,651.39539,558,675.731,844,457,531.62-449,619,508.85
期末现金及现金等价物余额2,049,293,488.223,008,138,815.334,313,037,671.222,468,580,139.6
最新报告期:2024-11-10
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
招商证券方秋实,许菲菲1.251.451.682024-11-10
中信建投刘若飞,贺菊颖1.281.471.692024-11-07
中信证券陈竹1.301.511.842024-11-04
东吴证券冉胜男,朱国广1.281.511.752024-11-03
浙商证券孙建,司清蕊1.211.451.652024-11-03
TOP↑